BBA
ASND icon

Baker Bros. Advisors’s Ascendis Pharma ASND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,954,855
Closed -$605M 107
2022
Q4
$605M Buy
4,954,855
+102,200
+2% +$12.5M 3.63% 6
2022
Q3
$501M Hold
4,852,655
3.28% 6
2022
Q2
$451M Buy
4,852,655
+311,051
+7% +$28.9M 2.56% 6
2022
Q1
$533M Hold
4,541,604
3.06% 6
2021
Q4
$611M Hold
4,541,604
2.97% 7
2021
Q3
$724M Buy
4,541,604
+1,001,334
+28% +$160M 3.18% 5
2021
Q2
$466M Hold
3,540,270
2.05% 7
2021
Q1
$456M Hold
3,540,270
1.98% 9
2020
Q4
$590M Hold
3,540,270
2.22% 10
2020
Q3
$546M Buy
3,540,270
+150,000
+4% +$23.1M 2.18% 8
2020
Q2
$501M Hold
3,390,270
2.21% 8
2020
Q1
$382M Hold
3,390,270
2.35% 8
2019
Q4
$472M Hold
3,390,270
2.51% 9
2019
Q3
$327M Hold
3,390,270
2.22% 9
2019
Q2
$390M Hold
3,390,270
2.65% 9
2019
Q1
$399M Buy
3,390,270
+552,918
+19% +$65.1M 2.55% 9
2018
Q4
$178M Hold
2,837,352
1.46% 9
2018
Q3
$201M Hold
2,837,352
1.32% 10
2018
Q2
$189M Hold
2,837,352
1.42% 10
2018
Q1
$186M Buy
2,837,352
+218,534
+8% +$14.3M 1.57% 8
2017
Q4
$105M Buy
2,618,818
+269,978
+11% +$10.8M 0.91% 10
2017
Q3
$85.1M Buy
2,348,840
+597,377
+34% +$21.7M 0.69% 12
2017
Q2
$48.6M Buy
1,751,463
+400,000
+30% +$11.1M 0.43% 19
2017
Q1
$37.8M Buy
1,351,463
+328,197
+32% +$9.19M 0.31% 25
2016
Q4
$20.7M Buy
1,023,266
+277,745
+37% +$5.62M 0.2% 34
2016
Q3
$15M Hold
745,521
0.14% 44
2016
Q2
$9.89M Buy
745,521
+240,000
+47% +$3.18M 0.1% 53
2016
Q1
$9.38M Hold
505,521
0.1% 58
2015
Q4
$9.26M Buy
505,521
+69,981
+16% +$1.28M 0.08% 63
2015
Q3
$7.71M Buy
435,540
+335,540
+336% +$5.94M 0.07% 67
2015
Q2
$1.77M Hold
100,000
0.02% 109
2015
Q1
$1.74M Buy
+100,000
New +$1.74M 0.01% 109